Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

CRMP5 Controls Glioblastoma Cell Proliferation and Survival through Notch-Dependent Signaling.

Moutal A, Honnorat J, Massoma P, Désormeaux P, Bertrand C, Malleval C, Watrin C, Chounlamountri N, Mayeur ME, Besançon R, Naudet N, Magadoux L, Khanna R, Ducray F, Meyronet D, Thomasset N.

Cancer Res. 2015 Sep 1;75(17):3519-28. doi: 10.1158/0008-5472.CAN-14-0631. Epub 2015 Jun 29.

2.

The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study.

Meyronet D, Dorey A, Massoma P, Rey C, Alix E, Silva K, Perrin C, Quadrio I, Perret-Liaudet A, Streichenberger N, Thomasset N, Honnorat J, Arzberger T, Kretzschmar H.

J Neural Transm (Vienna). 2015 Jul;122(7):975-91. doi: 10.1007/s00702-015-1378-4. Epub 2015 May 16.

PMID:
25976431
3.

VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation.

Meissirel C, Ruiz de Almodovar C, Knevels E, Coulon C, Chounlamountri N, Segura I, de Rossi P, Vinckier S, Anthonis K, Deléglise B, de Mol M, Ali C, Dassonville K, Loyens E, Honnorat J, Michotte Y, Rogemond V, Smolders I, Voets T, Vivien D, Vanden Berghe P, Van den Bosch L, Robberecht W, Chédotal A, Oliviero S, Dewerchin M, Schmucker D, Thomasset N, Salin P, Carmeliet P.

Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13782-7. doi: 10.1073/pnas.1100341108. Epub 2011 Jul 29.

4.

Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1.

Ruiz de Almodovar C, Coulon C, Salin PA, Knevels E, Chounlamountri N, Poesen K, Hermans K, Lambrechts D, Van Geyte K, Dhondt J, Dresselaers T, Renaud J, Aragones J, Zacchigna S, Geudens I, Gall D, Stroobants S, Mutin M, Dassonville K, Storkebaum E, Jordan BF, Eriksson U, Moons L, D'Hooge R, Haigh JJ, Belin MF, Schiffmann S, Van Hecke P, Gallez B, Vinckier S, Chédotal A, Honnorat J, Thomasset N, Carmeliet P, Meissirel C.

J Neurosci. 2010 Nov 10;30(45):15052-66. doi: 10.1523/JNEUROSCI.0477-10.2010.

5.

Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma.

Meyronet D, Massoma P, Thivolet F, Chalabreysse L, Rogemond V, Schlama A, Honnorat J, Thomasset N.

Am J Surg Pathol. 2008 Nov;32(11):1699-708. doi: 10.1097/PAS.0b013e31817dc37c.

PMID:
18769332
6.

Regulation of spine development by semaphorin3A through cyclin-dependent kinase 5 phosphorylation of collapsin response mediator protein 1.

Yamashita N, Morita A, Uchida Y, Nakamura F, Usui H, Ohshima T, Taniguchi M, Honnorat J, Thomasset N, Takei K, Takahashi T, Kolattukudy P, Goshima Y.

J Neurosci. 2007 Nov 14;27(46):12546-54.

7.

Modulating Sema3A signal with a L1 mimetic peptide is not sufficient to promote motor recovery and axon regeneration after spinal cord injury.

Mire E, Thomasset N, Jakeman LB, Rougon G.

Mol Cell Neurosci. 2008 Feb;37(2):222-35. Epub 2007 Oct 3.

8.

Collapsin response mediator protein 1 mediates reelin signaling in cortical neuronal migration.

Yamashita N, Uchida Y, Ohshima T, Hirai S, Nakamura F, Taniguchi M, Mikoshiba K, Honnorat J, Kolattukudy P, Thomasset N, Takei K, Takahashi T, Goshima Y.

J Neurosci. 2006 Dec 20;26(51):13357-62.

9.

Transient alterations in granule cell proliferation, apoptosis and migration in postnatal developing cerebellum of CRMP1-/- mice.

Charrier E, Mosinger B, Meissirel C, Aguera M, Rogemond V, Reibel S, Salin P, Chounlamountri N, Perrot V, Belin MF, Goshima Y, Honnorat J, Thomasset N, Kolattukudy P.

Genes Cells. 2006 Dec;11(12):1337-52.

10.

Functional interaction between matrix metalloproteinase-3 and semaphorin-3C during cortical axonal growth and guidance.

Gonthier B, Nasarre C, Roth L, Perraut M, Thomasset N, Roussel G, Aunis D, Bagnard D.

Cereb Cortex. 2007 Jul;17(7):1712-21. Epub 2006 Oct 4.

PMID:
17021275
11.

Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively.

Chabbert-de Ponnat I, Marie-Cardine A, Pasterkamp RJ, Schiavon V, Tamagnone L, Thomasset N, Bensussan A, Boumsell L.

Int Immunol. 2005 Apr;17(4):439-47. Epub 2005 Mar 3.

PMID:
15746246
12.

Differential MAP kinases activation during semaphorin3A-induced repulsion or apoptosis of neural progenitor cells.

Bagnard D, Sainturet N, Meyronet D, Perraut M, Miehe M, Roussel G, Aunis D, Belin MF, Thomasset N.

Mol Cell Neurosci. 2004 Apr;25(4):722-31.

PMID:
15080899
13.

MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum.

Vaillant C, Meissirel C, Mutin M, Belin MF, Lund LR, Thomasset N.

Mol Cell Neurosci. 2003 Oct;24(2):395-408.

PMID:
14572461
14.

Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders.

Charrier E, Reibel S, Rogemond V, Aguera M, Thomasset N, Honnorat J.

Mol Neurobiol. 2003 Aug;28(1):51-64. Review.

PMID:
14514985
15.
16.

Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor.

Bagnard D, Vaillant C, Khuth ST, Dufay N, Lohrum M, Puschel AW, Belin MF, Bolz J, Thomasset N.

J Neurosci. 2001 May 15;21(10):3332-41.

17.

Anti-beta4 integrin antibodies enhance migratory and invasive abilities of human colon adenocarcinoma cells and their MMP-2 expression.

Daemi N, Thomasset N, Lissitzky JC, Dumortier J, Jacquier MF, Pourreyron C, Rousselle P, Chayvialle JA, Remy L.

Int J Cancer. 2000 Mar 15;85(6):850-6.

18.

Spatial distributions of guidance molecules regulate chemorepulsion and chemoattraction of growth cones.

Bagnard D, Thomasset N, Lohrum M, Püschel AW, Bolz J.

J Neurosci. 2000 Feb 1;20(3):1030-5.

19.

Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.

Vaillant C, Didier-Bazès M, Hutter A, Belin MF, Thomasset N.

J Neurosci. 1999 Jun 15;19(12):4994-5004.

20.

Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development.

Thomasset N, Lochter A, Sympson CJ, Lund LR, Williams DR, Behrendtsen O, Werb Z, Bissell MJ.

Am J Pathol. 1998 Aug;153(2):457-67.

21.

A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1.

Desprez PY, Lin CQ, Thomasset N, Sympson CJ, Bissell MJ, Campisi J.

Mol Cell Biol. 1998 Aug;18(8):4577-88.

22.

Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I).

Giraudon P, Buart S, Bernard A, Thomasset N, Belin MF.

Prog Neurobiol. 1996 Jun;49(2):169-84. Review.

PMID:
8844825
23.

Extracellular matrix remodeling and the regulation of epithelial-stromal interactions during differentiation and involution.

Werb Z, Sympson CJ, Alexander CM, Thomasset N, Lund LR, MacAuley A, Ashkenas J, Bissell MJ.

Kidney Int Suppl. 1996 May;54:S68-74. Review.

24.

Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways.

Lund LR, Rømer J, Thomasset N, Solberg H, Pyke C, Bissell MJ, Danø K, Werb Z.

Development. 1996 Jan;122(1):181-93.

26.

Expression of the alpha 6, beta 1 and beta 4 integrin subunits, basement membrane organization and proteolytic capacities in low and high metastatic human colon carcinoma xenografts.

Daémi N, Vallet T, Thomasset N, Jacquier MF, Zebda N, Doré JF, Sordat B, Rémy L.

Invasion Metastasis. 1995;15(3-4):103-15.

PMID:
8621266
27.

Therapeutic effects of D-aspartic acid beta-hydroxamate (DAH) on Friend erythroleukemia.

Tournaire R, Malley S, Hamedi-Sangsari F, Thomasset N, Grange J, Dore JF, Vila J.

Int J Cancer. 1994 Aug 1;58(3):420-5.

PMID:
8050823
28.

Selective cytotoxicity of L-glutamic acid gamma-monohydroxamate (GAH) for melanoma tumor cells.

Thomasset N, Chabanas A, Tournaire R, Malley S, Navarro C, Lawrence JJ, Doré JF, Vila J.

Anticancer Res. 1993 Sep-Oct;13(5A):1393-8.

PMID:
8239510
29.

Inhibition of malate-aspartate shuttle by the antitumor drug L-glutamic acid gamma-monohydroxamate in L1210 leukemia cells.

Thomasset N, Goetsch L, Hamedi-Sangsari F, Tournaire R, Malley S, Navarro C, Doré JF, Vila J.

Int J Cancer. 1992 May 8;51(2):329-32. No abstract available.

PMID:
1568800
30.

Anti-tumoral activity of L and D isomers of aspartic acid beta-hydroxamate on L5178Y leukemia.

Thomasset N, Hamedi-Sangsari F, Tournaire R, Navarro C, Malley S, Goetsch L, Grange J, Vila J.

Int J Cancer. 1991 Sep 30;49(3):421-4.

PMID:
1917141
31.

Selective effect of trichotecolone on hemopoietic tumor cells.

Goetsch L, Thomasset N, Vila J, Philip I, Doré JF.

Anticancer Res. 1990 Jul-Aug;10(4):1013-7.

PMID:
2382972
32.

In vitro and in vivo anti-tumor activity of L-glutamic acid gamma-monohydroxamate against L1210 leukemia and B16 melanoma.

Vila J, Thomasset N, Navarro C, Doré JF.

Int J Cancer. 1990 Apr 15;45(4):737-43.

PMID:
2323850
33.

Use of MTT colorimetric assay to measure cell activation.

Gerlier D, Thomasset N.

J Immunol Methods. 1986 Nov 20;94(1-2):57-63.

PMID:
3782817
35.
36.

Properties of human adenoviruses 5 and 7 grown in guinea-pig cells.

Thomasset N, Chardonnet Y.

Arch Virol. 1980;66(4):353-8.

PMID:
7447710
37.

Study of human T and B lymphocytes with heterologous antisera. III. Immunofluorescence studies on tonsil sections.

Lamelin JP, Thomasset N, Andre C, Brochier J, Revillard JP.

Immunology. 1978 Sep;35(3):463-9.

Supplemental Content

Loading ...
Support Center